Colors of Hope in The Lancet Oncology

Colors of Hope in The Lancet Oncology

blogpost383_1At The Max Foundation, increasing global access to treatment for people around the world living with cancer is a core element of our mission. But access to treatment is only one piece in helping all people facing cancer live with dignity and hope. Fostering care and support for patients processing the hardships of cancer is essential.

The Colors of Hope Art Collection began as a project of The Max Foundation in 2005 in an effort to provide a creative outlet for people impacted by a cancer diagnosis. Through the Colors of Hope Art Collection, people living with cancer and their caregivers are invited to convey their experience through art. Since the project’s inception, we have received over 2,000 works of art that tell a complex yet common story. From fear and confusion, to acceptance and love, the emotional spectrum shared through the artwork provides a glimpse into the artists’ struggles and hope.

For their 2015 journal covers, The Lancet Oncology is featuring pieces from the Colors of Hopegallery. We are excited to see each monthly issue feature a different piece of art, and for that art to be shared with cancer practitioners and the community more broadly. Scroll through the gallery above to see the covers released so far and visit The Lancet Oncology for future issues. Read more about the Colors of Hope Art Collection.

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • Keeping Our Cool: Developing a Cold-Chain to Further Treatment Access

    Keeping Our Cool: Developing a Cold-Chain to Further Treatment Access

    A “cold-chain” product must remain within a specific temperature range at all times. On days- or weeks-long international shipments, it’s especially challenging (and expensive) to keep medicine at a constant temperature. Despite the inherent challenges, adding cold-chain capability is well worth the effort for the patients we support. By doing so, The Max Foundation will be able to better meet the needs of patients who are unresponsive to tablet therapies.

  • Announcing the Excellence in Patient Advocacy Award Winner

    Announcing the Excellence in Patient Advocacy Award Winner

    At The Max Foundation we are all about patients; deeply, profoundly, committed to patients and by extension their families and communities. To continue to foster this commitment, once a year we honor a team member who has exemplified our values and beliefs with the Excellence in Patient Advocacy Award. We are proud to announce the….

  • Meet Max Partner Physician – Dr. Johanna Rapanarilala

    Meet Max Partner Physician – Dr. Johanna Rapanarilala

    Introducing Dr. Johanna Rapanarilala from Seychelles! She has worked as an oncologist for more than 20 years and has been a Max partner physician since 2012. Learn more about her below. Describe a typical work week From Monday to Friday, I start at 7 a.m. with a review of my daily plan. Followed by ward….